These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33622080)
61. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells. Figueiredo C; Blaszczyk R J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449 [TBL] [Abstract][Full Text] [Related]
62. Methods for genetic modification of megakaryocytes and platelets. Pendaries C; Watson SP; Spalton JC Platelets; 2007 Sep; 18(6):393-408. PubMed ID: 17763148 [TBL] [Abstract][Full Text] [Related]
63. Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets. Wang J; Chen S; Zhang C; Stegeman S; Pfaff-Amesse T; Zhang Y; Zhang W; Amesse L; Chen Y PLoS One; 2012; 7(8):e44300. PubMed ID: 22952951 [TBL] [Abstract][Full Text] [Related]
64. Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors. Jarocha D; Vo KK; Lyde RB; Hayes V; Camire RM; Poncz M Blood Adv; 2018 Mar; 2(6):597-606. PubMed ID: 29545255 [TBL] [Abstract][Full Text] [Related]
65. Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34 Martinez AF; Miller WM Stem Cells Transl Med; 2019 Jul; 8(7):658-670. PubMed ID: 30848565 [TBL] [Abstract][Full Text] [Related]
66. IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. Nishimura S; Nagasaki M; Kunishima S; Sawaguchi A; Sakata A; Sakaguchi H; Ohmori T; Manabe I; Italiano JE; Ryu T; Takayama N; Komuro I; Kadowaki T; Eto K; Nagai R J Cell Biol; 2015 May; 209(3):453-66. PubMed ID: 25963822 [TBL] [Abstract][Full Text] [Related]
67. Determination Thuku NW; Shikuku K; Mbugua A Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628 [TBL] [Abstract][Full Text] [Related]
68. Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets. Hirata S; Murata T; Suzuki D; Nakamura S; Jono-Ohnishi R; Hirose H; Sawaguchi A; Nishimura S; Sugimoto N; Eto K Stem Cells Transl Med; 2017 Mar; 6(3):720-730. PubMed ID: 28297575 [TBL] [Abstract][Full Text] [Related]
69. Infusion of mature megakaryocytes into mice yields functional platelets. Fuentes R; Wang Y; Hirsch J; Wang C; Rauova L; Worthen GS; Kowalska MA; Poncz M J Clin Invest; 2010 Nov; 120(11):3917-22. PubMed ID: 20972336 [TBL] [Abstract][Full Text] [Related]
70. Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Moreau T; Evans AL; Vasquez L; Tijssen MR; Yan Y; Trotter MW; Howard D; Colzani M; Arumugam M; Wu WH; Dalby A; Lampela R; Bouet G; Hobbs CM; Pask DC; Payne H; Ponomaryov T; Brill A; Soranzo N; Ouwehand WH; Pedersen RA; Ghevaert C Nat Commun; 2016 Apr; 7():11208. PubMed ID: 27052461 [TBL] [Abstract][Full Text] [Related]
71. Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production. Krisch L; Brachtl G; Hochmann S; Andrade AC; Oeller M; Ebner-Peking P; Schallmoser K; Strunk D Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360992 [TBL] [Abstract][Full Text] [Related]
72. Intersecting Worlds of Transfusion and Transplantation Medicine: An International Symposium Organized by the Canadian Blood Services Centre for Innovation. Hodgkinson KM; Kiernan J; Shih AW; Solh Z; Sheffield WP; Pineault N Transfus Med Rev; 2017 Jul; 31(3):183-192. PubMed ID: 28385575 [TBL] [Abstract][Full Text] [Related]
73. Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors. Eicke D; Baigger A; Schulze K; Latham SL; Halloin C; Zweigerdt R; Guzman CA; Blasczyk R; Figueiredo C Sci Rep; 2018 Jul; 8(1):10146. PubMed ID: 29977045 [TBL] [Abstract][Full Text] [Related]
74. Road blocks in making platelets for transfusion. Thon JN; Medvetz DA; Karlsson SM; Italiano JE J Thromb Haemost; 2015 Jun; 13 Suppl 1(Suppl 1):S55-62. PubMed ID: 26149051 [TBL] [Abstract][Full Text] [Related]
75. Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line. Tozawa K; Ono-Uruga Y; Yazawa M; Mori T; Murata M; Okamoto S; Ikeda Y; Matsubara Y Blood; 2019 Feb; 133(7):633-643. PubMed ID: 30487128 [TBL] [Abstract][Full Text] [Related]
76. Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells. Pick M Methods Mol Biol; 2016; 1307():371-8. PubMed ID: 24297316 [TBL] [Abstract][Full Text] [Related]
77. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells. Takayama N; Eto K Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710 [TBL] [Abstract][Full Text] [Related]
78. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. Takayama N; Nishimura S; Nakamura S; Shimizu T; Ohnishi R; Endo H; Yamaguchi T; Otsu M; Nishimura K; Nakanishi M; Sawaguchi A; Nagai R; Takahashi K; Yamanaka S; Nakauchi H; Eto K J Exp Med; 2010 Dec; 207(13):2817-30. PubMed ID: 21098095 [TBL] [Abstract][Full Text] [Related]
79. FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly. Jurak Begonja A; Hoffmeister KM; Hartwig JH; Falet H Blood; 2011 Aug; 118(8):2285-95. PubMed ID: 21652675 [TBL] [Abstract][Full Text] [Related]
80. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Shin JW; Swift J; Spinler KR; Discher DE Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11458-63. PubMed ID: 21709232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]